
1. Technology overview
AMI Inc. is a research-driven medical startup headquartered in Kagoshima, Japan, with other sites in Kumamoto, Kyoto and Tokyo. Its mission is access to optimal care anytime, anywhere, for anyone, and it works on redefining auscultation with both hardware and software.
Cardio-EGG (heart sound examination device, AMI-SSS01 series) records heart sounds and ECG simultaneously, with emphasis on sound quality, and quantifies sound features and frequencies. The company builds deep learning models on this data to support diagnosis of heart disease. Cloud Choshin is a remote medical support system for sharing heart sound, ECG and analysis results among clinicians.
2. Highlighted features & specifications
- Cardio-EGG device: Heart sound examination device (AMI-SSS01 series) that records heart sound and ECG together.
- Sound quantification: Quantifies sound features and frequencies rather than only visualizing them.
- Deep learning models: Machine learning on linked hardware and clinical data to support heart disease diagnosis.
- Cloud Choshin: Remote medical support system for sharing heart sound, ECG and analysis results.
- Task shifting: Designed so various medical staff can perform exams under a physician's instruction.
3. Potential application
Community clinics could screen patients for heart disease with non-specialist staff and send results to a cardiologist. Hospitals could use remote sharing for referral decisions. Health check centers could add a heart sound and ECG test to routine checkups.
4. Benefits
Captures heart sound and ECG at the same time in one exam. Allows various medical staff to take part in testing under a physician's direction, supporting task shifting. Enables remote sharing of results between sites. The company holds ISO/IEC 27001 certification for its head office.
5. Market trends & opportunities
Digital stethoscopes and AI-assisted auscultation are expanding as cardiology specialists are scarce outside large cities. Remote cardiac screening fits community clinics and rural health stations in Vietnam and Southeast Asia, where heart valve disease and heart failure screening capacity is limited.
6. Other information
Headquartered in Kagoshima, Japan, with sites in Kumamoto, Kyoto and Tokyo. ISO/IEC 27001 certified. Won the Circulation Journal Awards 2025 (Clinical Investigation category) in February 2026; paper published in Clinical Cardiology in October 2026.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































